Search Results 241-250 of 994 for 씨밀레토토

1. Return of Results of Pharmacogenomic Testing for Genes Involved in Metabolism of 5FU and Capecitibine - Mayo Clinic

   About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...

2. A Study to Evaluate Firstline Pembrolizumab Alone or in Combination with Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients with Stage IV Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   Drugs used in chemotherapy, such as pemetrexed and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

3. Study of Pomalidomide for Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma and Newly Diagnosed or Relapsed/Refractory Intraocular Lymphoma - Mayo Clinic

   As such, pomalidomide is a promising immunomodulator to be tested in a clinical trial for CNS lymphoma. It works by killing the lymphoma cells directly as well ...

4. A Study to Evaluate Stool Samples for Use in IVD Product Development - Mayo Clinic

   This study will provide archived, clinical residual stool specimens to Meridian Bioscience, Inc. These specimens will be used by Meridian to perform research ...

5. Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery - Mayo Clinic

   About this study. RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

6. Mayo Clinic COVID-19 Pandemic Response Stool Biobank (Prospective)

   About this study. The purpose of this study is to prospectively collect longitudinal stool specimens and corresponding clinical and patient provided data ...

7. A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   This study is evaluating the efficacy of acalabrutinib in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with ...

8. CC-4047 in Treating Patients With Myelofibrosis - Mayo Clinic

   About this study. RATIONALE: Biological therapies, such as CC-4047, may stimulate the immune system in different ways and stop cancer cells from growing.

9. Study of Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis - Mayo Clinic

   The primary objective of this study is to evaluate the safety and effectiveness of inhaled treprostinil in subjects with Idiopathic Pulmonary Fibrosis (IPF).

10. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

    About this study. Phase I Dose Escalation: Primary objective is to determine the MTD and the recommended dose for Phase I Extension.